Skip to main content
editorial
. 2021 Feb 15;10(2):85–93. doi: 10.1159/000514312

Table 4.

Pharmacological inhibitory kinase activity of regorafenib and its metabolites

Gene symbol Kd, nmol/L
regorafenib* M-2 M-5
VEGFR-2 57/28 29 31
PDGFRA 21/19 7.3 11
PDGFRB 19/8.3 11 11
KIT 35/6.9 9.8 5.8
RET 7.7/5.2 7.6 5.8
CSF1R 43/10 21 13
FLT3 9.6/4.8 6.7 2.6
RAF1 87/59 130 66
BRAF 42/52 24 17

M-2, M-5: metabolites of regorafenib.

*

Duplicate Kd values are given.